0001415889-23-002458.txt : 20230214
0001415889-23-002458.hdr.sgml : 20230214
20230214164613
ACCESSION NUMBER: 0001415889-23-002458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230210
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laccona Nicholas
CENTRAL INDEX KEY: 0001886497
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36845
FILM NUMBER: 23630775
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001600132
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473116175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-574-4770
MAIL ADDRESS:
STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: Bellerophon Therapeutics LLC
DATE OF NAME CHANGE: 20140213
4
1
form4-02142023_040248.xml
X0306
4
2023-02-10
0001600132
Bellerophon Therapeutics, Inc.
BLPH
0001886497
Laccona Nicholas
184 LIBERTY CORNER ROAD
SUITE 302
WARREN
NJ
07059
false
true
false
false
FINANCIAL OFFICER, (PFO & PAO)
Stock Options (right to buy)
1.52
2023-02-10
4
A
0
50000
1.52
A
2033-02-10
Common Stock
50000
50000
D
This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.
/s/ Nicholas Laccona
2023-02-14